539 Genetic and pharmacological inhibition of TDO and KMO can increase KYNA, but not the level of neurotoxic product 3-HK, thereby improving the symptoms of neurodegeneration
A quick clinical reminder of what you need to know: Rifampin (R = Red): Warn patients about red-orange body fluids and permanent staining of contact lenses
Reconstitute 3.0 mL BAC water Concentration 26.7 mg/mL total blend 1 unit (0.01 mL) ~267 mcg total blend Typical cycle 4-6 weeks Dose selector Component Delivery by Titration Step GHK-Cu:~1.25 mg KPV:~250 mcg BPC-157:~250 mcg TB-500:~250 mcg Selector options mirror the representative titration table above
however, bioequivalence of JANUMET with coadministered sitagliptin and metformin HCl tablets was demonstrated
(Youre going to get blitzed, Koniver remembers Huberman saying.) On the podcast, Koniver said that almost everyone I could think of can benefit from peptides, and he highlighted an awesome, supersafe example called BPC-157